Watchlist Price Alert

ArriVent BioPharma Inc. Common Stock (AVBP)

NASDAQ: AVBP · Real-Time Price · USD

19.94

0.14 (0.71%)

May 08, 2025, 1:48 PM - Market open

ArriVent BioPharma Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-80.49M	-69.33M	-36.91M	-51.61M
Depreciation & Amortization	n/a	n/a	n/a	n/a
Stock-Based Compensation	3.21M	895K	424K	66.67K
Other Working Capital	7.82M	11.22M	-9.95M	-4.23M
Other Non-Cash Items	n/a	n/a	-2.38M	42.67M
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	7.07M	12.6M	-7.15M	-3.94M
Operating Cash Flow	-70.21M	-55.84M	-43.63M	-12.59M
Capital Expenditures	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	-194.16M	-25M	n/a	n/a
Sales Maturities Of Investments	1.7M	25M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-40M
Investing Cash Flow	-192.47M	n/a	n/a	-40M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	631K	n/a	15K	119.82M
Financial Cash Flow	186.58M	42.86M	169.72M	89.87M
Net Cash Flow	-76.1M	-12.98M	126.09M	37.28M
Free Cash Flow	-70.21M	-55.84M	-43.63M	-12.59M